The efficacy of a dose-escalated application of transdermal nicotine plus sulpiride in Tourette's syndrome

European Psychiatry

Volumn 11, Issue 4, 1996, Pages 204-206

  Dursun, S M ^a   Reveley, M A ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

tics; Tourette's syndrome; transdermal nicotine patch; treatment

Indexed keywords

NICOTINE; SULPIRIDE;

ADOLESCENT; ARTICLE; CASE REPORT; DOSE RESPONSE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; PRIORITY JOURNAL; RATING SCALE; TRANSDERMAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0029743334     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-9338(96)88392-1     Document Type: Article

References (10)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM-III-R). Washington, DC: APA, 1987
2. Bannet J, Belmaker RH (eds). New Directions in Tardive Dyskinesia Research. Basel: Karger, 1983
3. Davila DG, Hurt RD, Offord KP, Harris CD, Shepard JW. Acute effects of transdermal nicotine on sleep architecture, snoring and sleep-disordered breathing in non-smokers. Am J Respir Crit Care Med 1994;150:469-74
4. Dursun SM, Reveley MA, Bird R, Stirton F. Long-lasting improvement of Tourette's syndrome with transdermal nicotine. Lancet 1994;344:1577
5. Gerlach J, Reisby N, Randup A. Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. Psychopharmacologia 1974;34:21-35
6. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989;28:566-73
7. McConville BH, Sanberg PR, Fogelson MH, King J, Cirino P, Parker KW, Norman AB. The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tics severity and frequency in Tourette's disorder. Biol Psychiatry 1992;31:832-40
8. Richelson E. Neuroleptic affinities for human brain receptors and their use in predicting adverse effects. J Clin Psychiatry 1984;45:331-6
9. Sethy VM, Vanwoert MH. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists. Res Commun Chem Pathol Pharmacol 1974;8: 13-28
10. Silver AA, Sanberg PR. Transdermal nicotine patch and potentiation of haloperidol in Tourette's syndrome. Lancet 1993; 342:182